Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient

A 43‐year‐old man who was treated with interferon‐beta for multiple sclerosis was presented with hypertension, headache, nausea/vomiting, blurred vision, and renal dysfunction. The treatment with drugs and dialysis relieved the symptoms. Despite plasmapheresis is known to cause improvement in renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Malekzadeh, Masoud Mohammad, Alizadeh, Reza, Aghsaeifard, Ziba, Sahraian, Mohammad Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303857/
https://www.ncbi.nlm.nih.gov/pubmed/32577265
http://dx.doi.org/10.1002/ccr3.2808
_version_ 1783548150289530880
author Malekzadeh, Masoud Mohammad
Alizadeh, Reza
Aghsaeifard, Ziba
Sahraian, Mohammad Ali
author_facet Malekzadeh, Masoud Mohammad
Alizadeh, Reza
Aghsaeifard, Ziba
Sahraian, Mohammad Ali
author_sort Malekzadeh, Masoud Mohammad
collection PubMed
description A 43‐year‐old man who was treated with interferon‐beta for multiple sclerosis was presented with hypertension, headache, nausea/vomiting, blurred vision, and renal dysfunction. The treatment with drugs and dialysis relieved the symptoms. Despite plasmapheresis is known to cause improvement in renal function, no such improvement was seen in patient.
format Online
Article
Text
id pubmed-7303857
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73038572020-06-22 Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient Malekzadeh, Masoud Mohammad Alizadeh, Reza Aghsaeifard, Ziba Sahraian, Mohammad Ali Clin Case Rep Case Reports A 43‐year‐old man who was treated with interferon‐beta for multiple sclerosis was presented with hypertension, headache, nausea/vomiting, blurred vision, and renal dysfunction. The treatment with drugs and dialysis relieved the symptoms. Despite plasmapheresis is known to cause improvement in renal function, no such improvement was seen in patient. John Wiley and Sons Inc. 2020-03-30 /pmc/articles/PMC7303857/ /pubmed/32577265 http://dx.doi.org/10.1002/ccr3.2808 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Malekzadeh, Masoud Mohammad
Alizadeh, Reza
Aghsaeifard, Ziba
Sahraian, Mohammad Ali
Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
title Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
title_full Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
title_fullStr Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
title_full_unstemmed Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
title_short Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
title_sort thrombotic microangiopathy in interferon‐beta‐treated multiple sclerosis patient
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303857/
https://www.ncbi.nlm.nih.gov/pubmed/32577265
http://dx.doi.org/10.1002/ccr3.2808
work_keys_str_mv AT malekzadehmasoudmohammad thromboticmicroangiopathyininterferonbetatreatedmultiplesclerosispatient
AT alizadehreza thromboticmicroangiopathyininterferonbetatreatedmultiplesclerosispatient
AT aghsaeifardziba thromboticmicroangiopathyininterferonbetatreatedmultiplesclerosispatient
AT sahraianmohammadali thromboticmicroangiopathyininterferonbetatreatedmultiplesclerosispatient

Ejemplares similares